However, studies identified activating mutations in GRM8 [50], implicating its involvement in the pathogenesis and progression of several malignancies, including neuroblastoma, lung cancer, glioma, and breast cancer [51, 52]. This evidence concerns the gene GRM8 and neuroblastoma.